About Impairment Science
Impairment Science is a private company based in Cambridge, Massachusetts, incorporated in 2018 in Delaware. It has reported $1,382,582 raised in two offerings on Form D since March 2020. Its chief executive is Robert Schiller.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 8, 2022 | Jun 8, 2023 | $1,287,082of $1.5M target | 17 | $75,711 | Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Mar 4, 2020 | Mar 16, 2020 | $95,500of $500K target | 4 | $23,875 | Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $1,382,582 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Impairment Science's Form D filed Jun 8, 2023.
MM
Michael Milburn
Director
PS
Peter Sparber
Director
MD
Murray Dalziel
Director
RS
Robert Schiller
Chief Executive Officer and director
Earlier filings also listed John Hayes (executive officer and director, last listed Mar 2020).